Singapore markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
215.63-0.71 (-0.33%)
At close: 04:00PM EDT
212.03 -3.60 (-1.67%)
After hours: 07:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 31.34B
Enterprise value 37.63B
Trailing P/E 27.06
Forward P/E 14.14
PEG Ratio (5 yr expected) 6.24
Price/sales (ttm)3.19
Price/book (mrq)2.12
Enterprise value/revenue 3.83
Enterprise value/EBITDA 18.46

Trading information

Stock price history

Beta (5Y monthly) -0.02
52-week change 3-22.44%
S&P500 52-week change 327.86%
52-week high 3319.76
52-week low 3211.02
50-day moving average 3229.64
200-day moving average 3251.96

Share statistics

Avg vol (3-month) 31.18M
Avg vol (10-day) 31.38M
Shares outstanding 5145.36M
Implied shares outstanding 6145.36M
Float 8144.81M
% held by insiders 10.69%
% held by institutions 193.04%
Shares short (15 Mar 2024) 42.66M
Short ratio (15 Mar 2024) 42.02
Short % of float (15 Mar 2024) 42.06%
Short % of shares outstanding (15 Mar 2024) 41.83%
Shares short (prior month 15 Feb 2024) 43.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 318 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 11.81%
Operating margin (ttm)19.32%

Management effectiveness

Return on assets (ttm)4.58%
Return on equity (ttm)8.24%

Income statement

Revenue (ttm)9.84B
Revenue per share (ttm)67.97
Quarterly revenue growth (yoy)-6.20%
Gross profit (ttm)N/A
EBITDA 2.38B
Net income avi to common (ttm)1.16B
Diluted EPS (ttm)7.98
Quarterly earnings growth (yoy)-54.60%

Balance sheet

Total cash (mrq)1.05B
Total cash per share (mrq)7.22
Total debt (mrq)7.43B
Total debt/equity (mrq)50.20%
Current ratio (mrq)2.00
Book value per share (mrq)102.14

Cash flow statement

Operating cash flow (ttm)1.55B
Levered free cash flow (ttm)971.06M